10.26402/jpp.2018.3.11 10 BedekovicV.MiseS.AnicT.StaresinicM.GjurasinM.KopljarM.et al (2003)
Description Overview DSIP (Delta Sleep Inducing Peptide) is an endogenous research peptide consisting of nine amino acids (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) that was originally isolated from cerebral venous blood of sleeping rabbits
Cost-benefit analysis Research cagrilintide monotherapy: Cost: $800-1,600/month Weight loss: 10-12% over 68 weeks Total investment: $12,000-24,000 (18 months) Per pound lost (220 lb person, 24 lbs): $500-1,000/lb CagriSema combination: Cagrilintide: $800-1,600/month Semaglutide: $150-300/month Total: $950-1,900/month Weight loss: 15-25% (33-55 lbs for 220 lb person) Total investment: $14,000-28,000 (18 months) Per pound lost: $250-850/lb Better value than monotherapy Comparison to bariatric surgery: Surgery: $15,000-25,000 upfront Weight loss: 25-35% One-time cost Permanent anatomical change CagriSema approaching surgery results without surgery Making it more affordable: Use maintenance doses after titration (lower cost) Consider semaglutide alone initially (cheaper, effective) Add cagrilintide if plateau Budget long-term (12-18 months minimum) Use our peptide cost calculator at SeekPeptides to budget your weight loss protocol accurately
Next, withdraw the necessary volume of diluent
Integrated Research Applications Epithalon is employed across several aging, regenerative, and endocrine research domains
Related Catalogs Get the latest insights from our blog If you believe that this page should be taken down, please follow our DMCA take down process here
